Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy

Roche Bets $4.8B on Spark Therapeutics and the Future of Gene Therapy

Source: 
Xconomy
snippet: 

Roche has agreed to buy Spark Therapeutics for $4.8 billion, the latest strong signal that major pharmaceutical companies are ready to gamble on the promise of gene therapy despite its uncertain commercial prospects.